semaglutide type 1 diabetes trial A clinical is currently recruiting in Sydney! The trial, called REducing Cardiometabolic Risk with in Type 1 diabetes (The RESET1 study), will investigate whether the use of GLP-1 Agonists Show Promise in

Taking the time for a relaxing bath can be a wonderful way to manage the stress that often accompanies health changes

Main Research Findings 1) Treatment with FOXO4-DRI was found to reduce age-related testosterone secretion insufficiency in aged animals by targeting Leydig cells

NU NNG GABA THP LIU C NH HNG TI SC KHE

Topical options are best used as a supplement tonot a replacement forinternal support

2-Oleoyl Glycerol (2-OG) The Claims : Found more frequently in experimental settings than in commercially available supplements, 2-OG is a lipid compound that activates receptors in the gut known to stimulate GLP-1 secretion, theoretically supporting satiety and appetite regulation